Team |
Michael Coyle, PhD
Michael Coyle, PhD

Michael Coyle, PhD


Technology Development

Michael is responsible for expanding and improving the technology platform at Life Edit Therapeutics. 

He previously held several positions at early-stage life sciences companies, including Applied Molecular Transport and Amunix, and focused on advancing delivery technologies for protein-based therapeutics. 

Michael received his PhD in Chemistry from the University of California, Berkeley, where he developed new methods to study cell signaling at membrane-membrane interfaces.

Connect with

Visionary science, driven by visionary values.

Our Mission

To rewrite the future by curing disease, making any edit, anywhere.

Our Vision

To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.

Our Values

We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.